News
Senator Mike Crapo, ChairmanSenate Committee on FinanceUnited States SenateWashington, DC 20510 Senator Ron Wyden, Ranking MemberSenate Committee on FinanceUnited States SenateWashington, DC 20510 Re: ...
FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback